A team of scientists from the Harvard Stem Cell Institute and the Boston Children’s Hospital have developed a method to increase the survival rate, and therefore the effectiveness, of transplanted mesenchymal stem cells [MSCs]. In an animal model, Dr. Juan Melero-Martin and his team of researchers co-transplanted MSCs with blood vessel-forming cells, enabling the stem cells to survive longer in a patient to reach their full regenerative potential.
The unique regenerative properties of mesenchymal stem cells are often activated by signals sent from other cells in the body. The co-transplant of blood vessels allow the MSCs to receive more of these signals from neighboring cells, which can make MSC treatments like bone grafts, tissue grafts, joint repair and other regenerative therapies, more effective.
To learn more about the value of preserving your own MSCs for use in future regenerative therapies and how to bank your own stem cells through a non-invasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.